Insulin induces airway smooth muscle contraction

British Journal of Pharmacology

Volumn 150, Issue 2, 2007, Pages 136-142

  Schaafsma, D ^a   Gosens, R ^a,b   Ris, J M ^a   Zaagsma, J ^a   Meurs, H ^a   Nelemans, S A ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Airway smooth muscle; Contraction; Guinea pig; Insulin; Prostaglandins; Rho kinase

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; INDOMETACIN; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; RHO KINASE; RHO KINASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; BREATHING MUSCLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; EXPERIMENTAL STUDY; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; SMOOTH MUSCLE CONTRACTION; STATISTICAL SIGNIFICANCE; TRACHEA MUSCLE;

ANIMALS; GUINEA PIGS; INSULIN; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PROSTAGLANDINS; RESPIRATORY MUCOSA; TRACHEA;

EID: 33846532232     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706985     Document Type: Article

References (42)

1. Amrani Y, Tliba O, Deshpande DA, Walseth TF, Kannan MS, Panettieri Jr RA (2004). Bronchial hyperresponsiveness: insights into new signaling molecules. Curr Opin Pharmacol 4: 230-234.
2. Begum N (2003). Insulin signaling in the vasculature. Front Biosci 8: s796-s804.
3. Belmonte KE, Fryer AD, Costello RW (1998). Role of insulin in antigen-induced airway eosinophilia and neuronal M2 muscarinic receptor dysfunction. J Appl Physiol 85: 1708-1718.
4. Belmonte KE, Jacoby DB, Fryer AD (1997). Increased function of inhibitory neuronal M2 muscarinic receptors in diabetic rat lungs. Br J Pharmacol 121: 1287-1294.
5. Catalli A, Janssen LJ (2004). Augmentation of bovine airway smooth muscle responsiveness to carbachol, KCl, and histamine by the isoprostane 8-iso-PGE2. Am J Physiol Lung Cell Mol Physiol 287: L1035-L1041.
6. Chang L, Chiang SH, Saltiel AR (2004). Insulin signaling and the regulation of glucose transport. Mol Med 10: 65-71.
7. Davies SP, Reddy H, Caivano M, Cohen P (2000). Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105.
8. Fukata Y, Amano M, Kaibuchi K (2001). Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22: 32-39.
9. Fuller RW, Dixon CM, Cuss FM, Barnes PJ (1987). Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis 135: 176-180.
10. Garg S, Rosenstock J, Silverman BL, Sun B, Konkoy CS, de la PA et al. (2006). Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes. Diabetologia 49: 891-899.
11. Goldie RG, Fernandes LB (2000). A possible mediator role for endothelin-1 in respiratory disease. Monaldi Arch Chest Dis 55: 162-167.
12. Gosens R, Meurs H, Bromhaar MM, McKay S, Nelemans SA, Zaagsma J (2002). Functional characterization of serum- and growth factor-induced phenotypic changes in intact bovine tracheal smooth muscle. Br J Pharmacol 137: 459-466.
13. Gosens R, Nelemans SA, Hiemstra M, Grootte Bromhaar MM, Meurs H, Zaagsma J (2003). Insulin induces a hypercontractile airway smooth muscle phenotype. Eur J Pharmacol 481: 125-131.
14. Gosens R, Schaafsma D, Grootte Bromhaar MM, Vrugt B, Zaagsma J, Meurs H et al. (2004a). Growth factor-induced contraction of human bronchial smooth muscle is Rho-kinase-dependent. Eur J Pharmacol 494: 73-76.
15. Gosens R, Schaafsma D, Meurs H, Zaagsma J, Nelemans SA (2004b). Role of Rho-kinase in maintaining airway smooth muscle contractile phenotype. Eur J Pharmacol 483: 71-78.
16. Gosens R, Schaafsma D, Nelemans SA, Halayko AJ (2006). Rho-kinase as a drug target for the treatment of airway hyperresponsiveness in asthma. Mini Rev Med Chem 6: 339-348.
17. Griffin BW, Klimko P, Crider JY, Sharif NA (1999). AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. J Pharmacol Exp Ther 290: 1278-1284.
18. Hallsworth MP, Moir LM, Lai D, Hirst SJ (2001). Inhibitors of mitogen-activated protein kinases differentially regulate eosinophil-activating cytokine release from human airway smooth muscle. Am J Respir Crit Care Med 164: 688-697.
19. Heinemann L, Pfutzner A, Heise T (2001). Alternative routes of administration as an approach to improve insulin therapy: update on dermal, oral, nasal and pulmonary insulin delivery. Curr Pharm Des 7: 1327-1351.
20. Henry RR, Mudaliar SR, Howland III WC, Chu N, Kim D, An B et al. (2003). Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects. Diabet Care 26: 764-769.
21. Hirst SJ (2000). Airway smooth muscle as a target in asthma. Clin Exp Allergy 30 (Suppl 1): 54-59.
22. Hollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS et al. (2004). Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial. Diabet Care 27: 2356-2362.
23. Hunt LM, Valenzuela MA, Pugh JA (1997). NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance. Diabet Care 20: 292-298.
24. Joos G, Pauwels R, van der Straeten M (1987). Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax 42: 779-783.
25. Kelly CR, Williams GW, Sharif NA (2003). Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors. J Pharmacol Exp Ther 304: 238-245.
26. Lenzer J (2006). Inhaled insulin is approved in Europe and United States. BMJ 332: 321.
27. McKay S, Sharma HS (2002). Autocrine regulation of asthmatic airway inflammation: role of airway smooth muscle. Respir Res 3: 11.
28. Papayianni M, Gourgoulianis KI, Molyvdas PA (2001). Insulin NO-dependent action on airways smooth muscles. Nitric Oxide 5: 72-76.
29. Polosa R, Holgate ST (1990). Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9]bradykinin in normal and asthmatic subjects. Am Rev Respir Dis 142: 1367-1371.
30. Quattrin T, Belanger A, Bohannon NJ, Schwartz SL (2004). Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabet Care 27: 2622-2627.
31. Range SP, Pang L, Holland E, Knox AJ (2000). Selectivity of cyclooxygenase inhibitors in human pulmonary epithelial and smooth muscle cells. Eur Respir J 15: 751-756.
32. Sakagami M (2004). Insulin disposition in the lung following oral inhalation in humans : a meta-analysis of its pharmacokinetics. Clin Pharmacokinet 43: 539-552.
33. Schaafsma D, Gosens R, Bos IS, Meurs H, Zaagsma J, Nelemans SA (2004). Allergic sensitization enhances the contribution of Rho-kinase to airway smooth muscle contraction. Br J Pharmacol 143: 477-484.
34. Schaafsma D, Gosens R, Bos S, Meurs H, Zaagsma J, Nelemans A (2005). Role of contractile prostaglandins and Rho-kinase in growth factor-induced airway smooth muscle contraction. Respir Res 6: 85.
35. Somlyo AP, Somlyo AV (2003). Ca2+ Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase. Physiol Rev 83: 1325-1358.
36. Steiner S, Pfutzner A, Wilson BR, Harzer O, Heinemann L, Rave K (2002). Technosphere/Insulin - proof of concept study with a new insulin formulation for pulmonary delivery. Exp Clin Endocrinol Diabet 110: 17-21.
37. Tsang F, Choo HH, Dawe GS, Wong WS (2002). Inhibitors of the tyrosine kinase signaling cascade attenuated thrombin-induced guinea pig airway smooth muscle cell proliferation. Biochem Biophys Res Commun 293: 72-78.
38. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T et al. (1997). Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994.
39. Wang CC, Gurevich I, Draznin B (2003). Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes 52: 2562-2569.
40. Watson N, Magnussen H, Rabe KF (1997). Inherent tone of human bronchus: role of eicosanoids and the epithelium. Br J Pharmacol 121: 1099-1104.
41. Wessler IK, Kirkpatrick CJ (2001). The Non-neuronal cholinergic system: an emerging drug target in the airways. Pulm Pharmacol Ther 14: 423-434.
42. Zambanini A, Newson RB, Maisey M, Feher MD (1999). Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 46: 239-246.